Literature DB >> 25724001

Clinical impact of minimal micropapillary pattern in invasive lung adenocarcinoma: prognostic significance and survival outcomes.

Geewon Lee1, Ho Yun Lee, Ji Yun Jeong, Joungho Han, Min Jae Cha, Kyung Soo Lee, Jhingook Kim, Young Mog Shim.   

Abstract

Micropapillary subtype has recently been established to be a distinct marker for poor prognosis in lung adenocarcinomas. According to the current classification of lung adenocarcinomas, all subtypes are listed semiquantitatively in 5% increments. In other words, a minimal amount of the micropapillary pattern, precisely <5% of the entire tumor is disregarded. Therefore, we sought to assess the prognostic significance and survival outcomes in patients with a micropapillary pattern proportion of <5% of the entire tumor. A total of 525 patients with lung adenocarcinoma were classified into 3 subgroups according to the presence and proportion of micropapillary subtype: (1) ≥5% of the micropapillary pattern (n=114); (2) <5% of the micropapillary pattern (n=115); and (3) absence (<1%) of the micropapillary pattern (n=296). Sex, TNM stage, lymph node status (N status), tumor size, and predominant subtype demonstrated a significant difference among the 3 subgroups. Overall survival (OS) and disease-free survival (DFS) were significantly different among the 3 subgroups (P=0.009 and 0.001 for OS and DFS, respectively). Furthermore, OS was significantly better in patients without the micropapillary pattern (<1%) than in those with <5% (P=0.034). At multivariate analyses, age (P=0.005) and N status (P=0.005) were independent prognostic factors influencing OS. In conclusion, our results demonstrated that even a small proportion of the micropapillary pattern, specifically <5% of the entire tumor has a significant prognostic impact on OS. N status remained an independent prognostic factor that negatively influenced OS.

Entities:  

Mesh:

Year:  2015        PMID: 25724001     DOI: 10.1097/PAS.0000000000000399

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  27 in total

1.  Implications of the Eighth Edition of the TNM Proposal: Invasive Versus Total Tumor Size for the T Descriptor in Pathologic Stage I-IIA Lung Adenocarcinoma.

Authors:  Koji Kameda; Takashi Eguchi; Shaohua Lu; Yang Qu; Kay See Tan; Kyuichi Kadota; Prasad S Adusumilli; William D Travis
Journal:  J Thorac Oncol       Date:  2018-09-07       Impact factor: 15.609

2.  Micropapillary histological subtype in lung adenocarcinoma of 2 cm or less: impact on recurrence and clinical predictors.

Authors:  Yukihiro Yoshida; Jun-Ichi Nitadori; Aya Shinozaki-Ushiku; Jiro Sato; Tempei Miyaji; Takuhiro Yamaguchi; Masashi Fukayama; Jun Nakajima
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-02-27

3.  Clinicopathological Significance of Micropapillary Pattern in Lung Adenocarcinoma.

Authors:  Jung-Soo Pyo; Joo Heon Kim
Journal:  Pathol Oncol Res       Date:  2017-07-06       Impact factor: 3.201

4.  Transition between morule-like and solid components may occur in solid-predominant adenocarcinoma of the lung: report of 2 cases with EGFR and KRAS mutations.

Authors:  Shogo Tajima; Kenji Koda
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 5.  Surgical pathology of early stage non-small cell lung carcinoma.

Authors:  Mary Beth Beasley; Francine R Dembitzer; Raja M Flores
Journal:  Ann Transl Med       Date:  2016-06

6.  Prognostic factors in curatively resected pathological stage I lung adenocarcinoma.

Authors:  Yikun Yang; Yousheng Mao; Lin Yang; Jie He; Shugeng Gao; Juwei Mu; Qi Xue; Dali Wang; Jun Zhao; Yushun Gao; Zhirong Zhang; Ningning Ding; Ding Yang
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

7.  Micropapillary or solid pattern predicts recurrence free survival benefit from adjuvant chemotherapy in patients with stage IB lung adenocarcinoma.

Authors:  Minjie Ma; Yunlang She; Yijiu Ren; Chenyang Dai; Lei Zhang; Huikang Xie; Chunyan Wu; Minglei Yang; Dong Xie; Chang Chen
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

8.  Significant difference in recurrence according to the proportion of high grade patterns in stage IA lung adenocarcinoma.

Authors:  Hyun Woo Jeon; Young-Du Kim; Sung Bo Sim; Mi Hyoung Moon
Journal:  Thorac Cancer       Date:  2021-05-25       Impact factor: 3.500

9.  Micropapillary lung adenocarcinoma and micrometastasis.

Authors:  Yang Qu; Rania G Aly; Yusuke Takahashi; Prasad S Adusumilli
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 3.005

10.  Integrated Analysis of Genomic and Immunological Features in Lung Adenocarcinoma With Micropapillary Component.

Authors:  Shirong Zhang; Yang Xu; Pan Zhao; Hua Bao; Xiyong Wang; Rui Liu; Rujun Xu; Jingjing Xiang; Hong Jiang; Junrong Yan; Xue Wu; Yang Shao; Jiafeng Liang; Qiong Wu; Zhihao Zhang; Shun Lu; Shenglin Ma
Journal:  Front Oncol       Date:  2021-06-17       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.